Home › Trial NCT02599779
A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients
- Trial IDNCT02599779
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorSunnybrook Health Sciences Centre
- Enrollment4
- Start date2016-12
- ConditionsStage IV Renal Cell Cancer AJCC V7
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.